Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AIM ImmunoTech Inc.Financial_Report.xls
EX-31.1 - EXHIBIT 31.1 - AIM ImmunoTech Inc.v311716_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - AIM ImmunoTech Inc.v311716_ex31-2.htm
10-Q - FORM 10-Q - AIM ImmunoTech Inc.v311716_10q.htm
EX-32.1 - EXHIBIT 32.1 - AIM ImmunoTech Inc.v311716_ex32-1.htm

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO
SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hemispherx Biopharma, Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles T. Bernhardt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: May 7, 2012

 

  /s/ Charles T. Bernhardt
  Charles T. Bernhardt, CPA
  Chief Financial Officer